In-Vivo Assessment of Adipose Allograft Extracellular Matrix in Abdominoplasty Patients

Inclusion Criteria * Scheduled to undergo elective abdominoplasty. * Able to provide informed consent. * Able to understand and comply with the study design and are willing to return for all of the research required follow-up visits. * BMI great than or equal to 23 and less than or equal to 35. * Thickness of subcutaneous tissue on abdominal wall is at least 2cm thick. * If a female, must test negative on a urine pregnancy test. * If a female, must be willing to utilize an acceptable method of birth control (i.e., oral contraceptives, condom with spermicide, etc.) for the duration of the study. Exclusion Criteria: * Thickness of subcutaneous tissue on abdominal wall is less than 2cm thick. * Previous liposuction at intended sites of treatment. * Actively taking immunosuppressive therapy including systemic steroids (intranasal/inhaled steroids are acceptable). * Actively receiving chemotherapy or radiation treatment. * Subjects with a life expectancy of less than 9 months, terminal conditions or factors making follow-up difficult (e.g.; no fixed address, telephone, etc.) * Subjects with intolerance to additional study-associated drugs/therapies (e.g.; lidocaine, etc.). * Subjects with known coagulopathy. * Subjects on chronic anticoagulants (e.g. Coumadin, etc.). * Subjects who are pregnant, lactating or planning pregnancy during the study period. * Subjects with abnormal blood chemistry or any abnormal laboratory finding considered clinically significant in that it would d…